Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nanobodies
Biotech
BioAge inks option agreement for Chinese biotech's obesity asset
BioAge and JiKang Therapeutics will work together to bring the APJ agonist nanobody to the beginning of IND-enabling studies.
Darren Incorvaia
Jun 3, 2025 2:06pm
MoonLake shines brighter as IL-17 drug scores latest phase 2 win
Nov 6, 2023 8:14am
Sanofi rethinks $2.5B IL-2 bet as phase 2 efficacy falls short
Oct 28, 2022 7:45am
Sanofi wagers $400M in biobucks to go after muscular dystrophy
Oct 4, 2022 8:00am
Carl June's latest CAR-T work taps llamas for GI cancers
Mar 29, 2022 9:00am
